Get the Weekly Intelligence Brief — top committee picks every Sunday.

GMED vs ITGR

Globus Medical vs Integer Holdings Corporation — AI-powered side-by-side comparison
GMED
Globus Medical
71
Buy
VS
ITGR
Integer Holdings Corporation
55
Watch
MetricGMEDITGR
AI Score 71 55
Price $85.12 $124.98
P/E Ratio 21.45× 33.89×
ROE 11.8% 5.9%
Revenue Growth YoY
Gross Margin 68.5% 23.7%
Debt / Equity 0.02× 0.79×
Dividend Yield 0.0% 0.0%
RSI (14) 75.9 86.8
Beta 0.954 0.613
Expected Upside +0.1%

AI Committee View

Current Innellis committee reasoning for GMED versus ITGR.
GMED leads by 16 points.

GMED scores 71/100 (Buy) versus ITGR at 55/100 (Watch).

GMED Committee View
75% agreement
4 analysts

The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is rsi at 76 is in overbought territory. The committee is constructive but not yet at full conviction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • RSI at 76 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
ITGR Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 49.8% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • EPS growing 62.0% YoY — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • P/E of 33.1 is moderate-to-rich — Value
  • RSI at 87 is in overbought territory — Technical
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
GMED Full Analysis ITGR Full Analysis